Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy

Study limitation reported by the research below: “KCCQ-OSS improvement was apparently attenuated in patients on background tafamidis, but this exploratory finding should be interpreted cautiously given multiple comparisons across endpoints.”